Viewpoints in Retina

Long-Term Anti-VEGF Delivery System Draws Closer to Primetime The Port Delivery System is a refillable intravitreal implant designed to deliver a continuous supply of ranibizumab into the vitreous. Is it as good as intravitreal ranibizumab injections?
Experts And Viewpoints, April 20, 2022
Reevaluating the Safety of Brolucizumab for Treating Wet AMD Further investigation is needed on the safety of brolucizumab for treating wet AMD.
Experts And Viewpoints, March 11, 2022
Increased Screen Time During COVID-19 May Accelerate Myopia Boom A new review article wrestles with the pandemic's possible ocular implications for children, who are home in front of their screens at levels like never before.
Experts And Viewpoints, March 25, 2021
Weighing the Risks of Treating Floaters With Vitrectomy Although vitrectomy for floaters is largely safe, the risk for subsequent retinal detachment and cataract surgery remains a concern.
Experts And Viewpoints, March 19, 2021
Is Face-Down Positioning After Macular Hole Surgery Still Needed? Dr Sophie Bakri comments on a study comparing postoperative closure rates between face-down and face-forward approaches.
Experts And Viewpoints, January 06, 2021
Does Residual Fluid Matter in Wet AMD? Dr Sophie Bakri surveys the data on how fluid presence and type affect visual outcomes after treat-and-extend anti-VEGF therapy.
Experts And Viewpoints, October 01, 2020
Should We Treat or Observe DME With Good Vision? Treating all patients with central-involved diabetic macular edema, regardless of their vision quality, may not be a clinically effective strategy.
Experts And Viewpoints, July 14, 2020
Novel Anti-VEGF Delivery System Aims to Reshape AMD Treatment Early results highlight the promise of a permanent, refillable port implant, which allows sustained delivery of ranibizumab.
Experts And Viewpoints, May 21, 2020
Is Treat-and-Extend Truly Effective for Diabetic Macular Edema? A 2-year study is the latest to highlight this approach's benefits, but its design also overlooks an important comparative treatment.
Experts And Viewpoints, August 29, 2019
What's the Mediterranean Diet's Value in AMD? A recent pooled analysis makes a compelling case for this diet's protective role, but establishing a direct causal role remains elusive.
Experts And Viewpoints, June 24, 2019
Anti-VEGF Efficacy in DME: Early Response Is Not Destiny New data from Protocol T shows that eyes with poor 12-week response often had good vision at 2 years without switching therapies.
Experts And Viewpoints, January 23, 2019
It's About Time: Brolucizumab Extends Treatment Effect in Wet AMD The latest phase 3 results show why this drug may be the promising treatment we've been waiting for.
Experts And Viewpoints, December 12, 2019
Anti-VEGF Effective in Persistent Diabetic Macular Edema A recent analysis associated three different anti-VEGF agents with meaningful vision gains through 2 years of follow-up.
Experts And Viewpoints, September 12, 2018
Anti-VEGF/PRP Regresses Diabetic Retinopathy Taking a closer look at PROTEUS, an intriguing study in patients with high-risk proliferative diabetic retinopathy.
Experts And Viewpoints, July 16, 2018
Treat-Extend-Stop Protocol for Wet AMD: Long-term Outcomes A retrospective study finds that a treat-extend-stop protocol using anti-VEGF agents for neovascular age-related macular degeneration is associated with positive long-term outcomes.
Experts And Viewpoints, March 30, 2018
Do Corticosteroids Improve Diabetic Macular Edema Outcomes? Drs Matt Starr and Sophie Bakri on a randomized trial studying the value of adding intravitreal dexamethasone to anti-VEGF therapy.
Experts And Viewpoints, January 30, 2018
New Anti-VEGF Agent Brolucizumab Shows Promise for AMD According to new research, brolucizumab, a new anti-VEGF for neovascular AMD, is noninferior to aflibercept and may offer longer dosing intervals.
Experts And Viewpoints, October 12, 2017
Should We WAVE Goodbye to Laser? This study helps answer a common clinical question as to whether peripheral laser to areas of retinal ischemia improves vision and reduces injection burden in patients with retinal vein occlusion.
Experts And Viewpoints, August 01, 2017
PVR and Steroid Implants -- A Good Fit? Have dexamethasone implants changed the treatment landscape of proliferative vitreoretinopathy? Dr Sophie Bakri 'eyes' the latest research.
Experts And Viewpoints, April 13, 2017
Aqueous Chlorhexidine for Intravitreal Injection Antisepsis Povidone-iodine is the preferred antiseptic for ocular procedures, but for those who have a sensitivity, is aqueous chlorhexidine a suitable alternative?
Experts And Viewpoints, January 20, 2017

No Results